MTE #32 Expanding the Donor Pool: Use of Hepatitis B Surface Antigen Positive Donors in Hepatitis B Seronegative Recipients

Nov 10 2025
Convention Center: Room 149, Level 1
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Robert J. Fontana, MD, FAASLD
Discussion Leader

Robert J. Fontana, MD, FAASLD

University of Michigan Hospitals and Health Centers
Reena Salgia, MD, FAASLD
Discussion Leader

Reena Salgia, MD, FAASLD

Description

Experts present information addressing the safety and efficacy of transplantation of HBsAg-positive donor organs into hepatitis B seronegative recipients and long-term management of hepatitis B post transplantation in this patient population. Topics include patient and graft survival, and posttransplant management including the role of hepatitis B immunoglobulin, long-term HBV suppressive managment, and HCC risk and surveillance.

Journey Maps

Objectives

  • Review the safety and efficacy of transplanting allografts from HBsAg-positive donors into hepatitis B seronegative recipients.
  • Describe the long-term management of hepatitis B in this population of transplant patients.
  • Explain the HCC risk and surveillance practices after transplantation in this patient population.